Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-10-10

Clinical Trial Update: The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia. [Phase 3]

View source ↗

Summary

This Clinical Trial Update reports on a Phase 3 study of tegaserod in patients with heartburn and dyspepsia, assessing mechanical sensitivity of the esophagus a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tegaserod (tegaserod)

Snippet

Sponsor: Novartis | Conditions: Heartburn, Dyspepsia | Phase 3 | Status: COMPLETED